Richard D Wood

Author PubWeight™ 56.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DNA polymerases and cancer. Nat Rev Cancer 2011 3.05
2 ERCC1 and non-small-cell lung cancer. N Engl J Med 2007 2.22
3 High-efficiency bypass of DNA damage by human DNA polymerase Q. EMBO J 2004 2.07
4 Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res 2009 2.03
5 DNA polymerase zeta (pol zeta) in higher eukaryotes. Cell Res 2008 2.02
6 Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Mol Cell 2006 1.79
7 POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic Acids Res 2003 1.76
8 Low-fidelity DNA synthesis by human DNA polymerase theta. Nucleic Acids Res 2008 1.65
9 Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res 2006 1.60
10 DNA repair: from molecular mechanism to human disease. DNA Repair (Amst) 2006 1.56
11 POLN, a nuclear PolA family DNA polymerase homologous to the DNA cross-link sensitivity protein Mus308. J Biol Chem 2003 1.53
12 Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol. J Biol Chem 2006 1.49
13 DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci U S A 2010 1.48
14 DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes. J Biol Chem 2007 1.44
15 DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct. DNA Repair (Amst) 2007 1.39
16 DDB1-DDB2 (xeroderma pigmentosum group E) protein complex recognizes a cyclobutane pyrimidine dimer, mismatches, apurinic/apyrimidinic sites, and compound lesions in DNA. J Biol Chem 2005 1.38
17 A human DNA helicase homologous to the DNA cross-link sensitivity protein Mus308. J Biol Chem 2001 1.36
18 Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int J Cancer 2004 1.34
19 Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage. Mol Cell Biol 2004 1.31
20 XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells. DNA Repair (Amst) 2006 1.25
21 DNA polymerase POLQ and cellular defense against DNA damage. DNA Repair (Amst) 2012 1.21
22 Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 2005 1.16
23 A unique error signature for human DNA polymerase nu. DNA Repair (Amst) 2006 1.16
24 DDB complexities. DNA Repair (Amst) 2003 1.16
25 Loss of DNA polymerase zeta enhances spontaneous tumorigenesis. Cancer Res 2010 1.15
26 Novel enzymatic function of DNA polymerase nu in translesion DNA synthesis past major groove DNA-peptide and DNA-DNA cross-links. Chem Res Toxicol 2010 1.12
27 Lesion bypass activity of DNA polymerase θ (POLQ) is an intrinsic property of the pol domain and depends on unique sequence inserts. J Mol Biol 2010 1.12
28 DNA polymerases and somatic hypermutation of immunoglobulin genes. EMBO Rep 2005 1.12
29 DNA polymerase zeta is required for proliferation of normal mammalian cells. Nucleic Acids Res 2012 1.05
30 Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiat Res 2009 1.03
31 Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation. Mol Carcinog 2008 1.00
32 Evolutionary conservation of residues in vertebrate DNA polymerase N conferring low fidelity and bypass activity. Nucleic Acids Res 2010 1.00
33 Dual role for mammalian DNA polymerase ζ in maintaining genome stability and proliferative responses. Proc Natl Acad Sci U S A 2013 0.97
34 Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs. Nat Commun 2013 0.89
35 Bypass specialists operate together. EMBO J 2009 0.88
36 Salicylanilide inhibitors of Toxoplasma gondii. J Med Chem 2012 0.87
37 Assaying for the dual incisions of nucleotide excision repair using DNA with a lesion at a specific site. Methods Mol Biol 2006 0.86
38 Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants. J Pharm Biomed Anal 2010 0.84
39 Replication of the 2,6-diamino-4-hydroxy-N(5)-(methyl)-formamidopyrimidine (MeFapy-dGuo) adduct by eukaryotic DNA polymerases. Chem Res Toxicol 2012 0.81
40 Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra. Anal Bioanal Chem 2010 0.81
41 New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability. Mol Cell 2007 0.81
42 Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data. Anal Bioanal Chem 2011 0.78
43 Repair synthesis assay for nucleotide excision repair activity using fractionated cell extracts and UV-damaged plasmid DNA. Methods Mol Biol 2006 0.77
44 Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques. Anal Chem 2010 0.77
45 Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study. Pharm Res 2015 0.76
46 Optimisation of the superplastic forming of a dental implant for bone augmentation using finite element simulations. Dent Mater 2004 0.75